Extension Application for Xeomin(R) for the New Indication Spasticity was Approved...
Today, Merz Pharmaceuticals announced that European health authorities have reached an agreement on a new indication of Xeomin® for the symptomatic treatment of post-stroke spasticity of th...
CNW Group via Yahoo! Finance,
Wed Nov 18 05:21:00 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News